Navigation Links
Genmab Announces HuMax-CD32b Pre-Clinical Program
Date:1/4/2008

Summary: Genmab has Announced a New Pre-Clinical Antibody Program Called

HuMax-CD32b.

COPENHAGEN, January 4 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today a new pre-clinical antibody program called HuMax-CD32b(TM). This fully human IgG1,k antibody targets the CD32b receptor found on immune cells and hematological tumors. HuMax-CD32b may have therapeutic potential in the treatment of B-cell chronic lymphocytic leukemia, small lymphocytic lymphoma, Burkitt's lymphoma, follicular lymphoma and diffuse large B-cell lymphoma.

The lead candidate for HuMax-CD32b was selected from a panel of over 60 antibodies based on its excellent selectivity and binding ability for the CD32b target and potent triggering of the immune system killing mechanism antibody-dependent cellular cytotoxicity (ADCC). The antibody was highly effective in suppressing tumor growth in in vivo mouse tumor models in which tumor growth was monitored by highly sensitive bioluminescence imaging.

In animal models, HuMax-CD32b has been shown to induce impressive anti-tumor responses. The CD32b receptor has an inhibitory role on immune cells and blockade of CD32b has been documented to strongly potentiate the therapeutic effects of other anti-tumor antibodies. An antibody targeting CD32b may thus be attractive for combination therapy with other antibodies.

"We believe HuMax-CD32b has great potential as a cancer therapeutic, both because of its impressive anti-tumor activity, and the potential for combination with other therapeutic antibodies, such as antibodies directed to CD20 or CD38." said Prof. Jan G. J. van de Winkel, Ph.D., Chief Scientific Officer at Genmab A/S.

About Genmab A/S

Genmab is a leading international biotechnology company focused on developing fully human antibody therapeutics for unmet medical needs. Using unique, cutting-edge antibody technology, Genmab's world class discovery and development t
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Roche Files IND for Second Genmab Antibody
2. Genmab A/S - R1507 Antibody to Enter Phase II Study to Treat Sarcoma
3. Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis
4. Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic
5. Genmab Announces Update on Recruitment of Patients in ofatumumab CLL Pivotal Study
6. Genmab Announces Results for the First Nine Months of 2007
7. Phase I Results Announced for R1507 From Genmabs Collaboration With Roche
8. Genmab Amends HuMax-CD4 Pivotal Study in CTCL
9. Genmab A/S - Company Announcement
10. Genmab Amends Ofatumumab Pivotal Study in NHL to Single Arm Study
11. Genmab Announces Asset Exchange Agreement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , BOSTON and COPENHAGEN, Nov. 30 /PRNewswire/...unced today that the Harvard Medical School ICCB-L...nized as a MicroRNA Screening Center of Excellence...l School, and associated hospitals and institution... and RNAi libraries. ,, MicroRNAs are a novel c...
(Date:11/30/2009)... , LONDON, November 30 /PRNewswire/...mpany, was named Europe,s fastest growing,Biotech/...y in the Deloitte,2009 Technology Fast 500 for EME...s annual ranking is based on a companies, five-yea... rate of 8,318% over this period. This,achievement...
(Date:11/29/2009)... release is available in German . , The con... modern physics. The most famous example is that o...eutrons. Now Prof. Bella Lake from Helmholtz-Zentr...cientists report for the first time an experimenta...n observed in a condensed matter system. , The c...
(Date:11/27/2009)... , DURHAM, N.C., Nov. 27 C...l initiate water-soluble carbon nanotube-based can...water-soluble carbon nanotubes, which have functio...n with cancer drugs, was developed in partnership ...jugated carbon nanotubes serves as a drug delivery...
Breaking Biology Technology:Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4Spinons -- confined like quarks 2North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2
... Key words: adenoviral vector • viral tra...l; gene delivery, , There is a req...ate lead candidate drugs arising from primary scre...ological assays. There is also a need in early-sta... as modulate the activity of, a plethora of molecu...
... M. Kenrick, S. Hancock, S. Stubbs, and N. Thoma...rdiff, UK , , Recent advances in s...oughput image analysis platforms such as the IN Ce...lysis of genes and proteins. Here, we describe the...reen fluorescent protein (GFP) ◊ cell cycle se...
...nd H.C. Birnboim , DNA Genotek Inc., Ott...ed with Oragene works well with TaqMan SNP Genotyp...thetase and apolipoprotein E genes were reliably ,...tion , Single-nucleotide polymorphisms ... to occur at 1 out of every 1,000 bases in t...
Other Biology Technology:Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 2Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 3Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 4Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 5Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 6Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 7Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 8Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 9Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system 10siRNA screening of the cell cycle with two dynamic GFP sensors (from Discovery Matters Issue 1, July 2005) 2siRNA screening of the cell cycle with two dynamic GFP sensors (from Discovery Matters Issue 1, July 2005) 3siRNA screening of the cell cycle with two dynamic GFP sensors (from Discovery Matters Issue 1, July 2005) 4siRNA screening of the cell cycle with two dynamic GFP sensors (from Discovery Matters Issue 1, July 2005) 5siRNA screening of the cell cycle with two dynamic GFP sensors (from Discovery Matters Issue 1, July 2005) 6siRNA screening of the cell cycle with two dynamic GFP sensors (from Discovery Matters Issue 1, July 2005) 7Oragene is compatible with TaqMan SNP genotyping 2Oragene is compatible with TaqMan SNP genotyping 3
(Date:11/26/2009)...st worked out a way of using recordings of birdson...ns. This is the first time sound recordings from a...te estimates of bird species, populations. Because...ical Society,s Journal of Applied Ecology , will ...r advance in our ability to monitor whale and dolp...
(Date:11/26/2009)...istant Staphylococcus Aureus ) and other drug-res...perature plasma prototype devices have been develo...ricidal cocktails. , Two prototype devices have ...healthy skin (e.g. hands and feet) in hospitals an...hreat; and another to shoot bacteria-killing agent...
(Date:11/25/2009)...fighters, police officers and ambulance workers fa...Center complex. They battled to save people from t... tackled fires and evacuated as many people as the...,000 people. And making their jobs even harder was...rkers and their relatives jammed mobile networks w...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3Longer Hormone Treatment May Improve Prostate Cancer Outlook 48526 1Longer Hormone Treatment May Improve Prostate Cancer Outlook 48526 2Longer Hormone Treatment May Improve Prostate Cancer Outlook 48526 3Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 1Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 2Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 3San Francisco Symposium Provides Training for Communities Looking to Develop Arts Programs That Unite Generations 48519 1San Francisco Symposium Provides Training for Communities Looking to Develop Arts Programs That Unite Generations 48519 2San Francisco Symposium Provides Training for Communities Looking to Develop Arts Programs That Unite Generations 48519 3
... Like a 1950,s Detroit automaker, it appears that ...d, sturdy chassis. , A new study combining advanc...ents by molecular biologists at Rice University an...t stable parts of a protein are also the parts tha... 13 issue of the journal Structure. , Nature ref...
... Researchers have found that a class of RNA molecu...n fact protect sex cells from self-destructing. Th...issue of the journal Cell. , Central to this disc...n. When a gene is ready to produce a protein, the ... The first strand produces a molecule called messe...
... New research offers tantalizing clues as to why s...ecome more aggressive or kill themselves. The res...science, which is published by the American Psycho...e University of Texas at Austin found that juvenil...ride, which is sold in the United States as Prozac...
Other Biology News:Protein folding: Building a strong foundation 2Scientists discover role for dueling RNAs 2Adolescent but not adult hamsters are more aggressive on low dose of fluoxetine 2
12(S)-HETE-d8, Deuterium Conjugated/Tagged from Cayman Chemical
Silencer Pre-designed siRNA, PAGE purified from Ambion
...eliably amplify unknown genomic DNA using our pat..., ready-to use components, at an extraordinarily c...ovided in each kit. The BAC End Amplification kit ...clones such as P1, YAC and BAC, and localized sub-...
Bis-acrylamide, Ultra Pure from Research Organics, Inc.
Biology Products: